午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

N-Fmoc-3-bromobenzyl-glycine

CAS No.
2137853-01-9
Chemical Name:
N-Fmoc-3-bromobenzyl-glycine
Synonyms
N-Fmoc-3-bromobenzyl-glycine;Glycine, N-[(3-bromophenyl)methyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
CBNumber:
CB54796416
Molecular Formula:
C24H20BrNO4
Molecular Weight:
466.32
MDL Number:
MFCD30749884
MOL File:
2137853-01-9.mol

N-Fmoc-3-bromobenzyl-glycine Properties

Boiling point 644.9±50.0 °C(Predicted)
Density 1.467±0.06 g/cm3(Predicted)
pka 3.82±0.10(Predicted)

N-Fmoc-3-bromobenzyl-glycine price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Acrotein NA-2184 N-Fmoc-3-bromobenzyl-glycine 97% 2137853-01-9 0.25g $165 2021-12-16 Buy
Acrotein NA-2184 N-Fmoc-3-bromobenzyl-glycine 97% 2137853-01-9 0.5g $247.5 2021-12-16 Buy
Acrotein NA-2184 N-Fmoc-3-bromobenzyl-glycine 97% 2137853-01-9 1g $366.66 2021-12-16 Buy
Product number Packaging Price Buy
NA-2184 0.25g $165 Buy
NA-2184 0.5g $247.5 Buy
NA-2184 1g $366.66 Buy

N-Fmoc-3-bromobenzyl-glycine Preparation Products And Raw materials

Raw materials

Preparation Products

N-Fmoc-3-bromobenzyl-glycine Suppliers

Global( 3)Suppliers
Supplier Tel Email Country ProdList Advantage
Nextpeptide Inc
+86-0571-81612335 +8613336028439 sales@nextpeptide.com China 19908 58
Amatek Scientific Co. Ltd. 0512-56316828 info@amateksci.com China 28805 58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd 13915962545 2881759498@qq.com China 8827 58
N-Fmoc-3-bromobenzyl-glycine Glycine, N-[(3-bromophenyl)methyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]- 2137853-01-9
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept